Phthalocyanine-nanoparticle conjugates for enhanced cancer photodynamic therapy

Key Points

• Enhanced cell death occurs due to increased production of reactive oxygen species (ROS) during photodynamic therapy.
• Key evidence shows that the utilization of phthalocyanine-nanoparticle conjugates greatly improves cancer treatment outcomes.
• The approach focuses on the innovative use of photodynamic therapy to activate photosensitizers and eradicate tumor cells.
• These findings may enable improved cancer treatment strategies using minimally invasive techniques with targeted effects.

Abstract